Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Well, which is it???????

Well, which is it???????

posted on Oct 27, 2009 05:56PM

CUPERTINO, Calif. – October 5, 2009 –

"Despite the risk of willful infringement in cases where companies delay licensing decisions on the basis of reexams, hundreds of companies have been awaiting the outcome of US’336 and are now reengaging in licensing discussions in light of the escalating royalty rate structure of the MMP Portfolio™ Licensing Program."

-or-

CUPERTINO, Calif. – October 27th, 2009

"We commend the Force10 Management team for its timely review of the MMP Portfolio and decisive action to assure that the distribution of Force 10 products will continue uninterrupted” said Roy Maharaj, Vice President, Licensing at Alliacense, adding “the recent success of several MMP patents in re-examinations at the USPTO have led a number of companies back to the negotiating table.”

Big difference between "hundreds" and "a number of" in my opinion. As I've said many times, don't forget who's putting out the PR's. I see no reason to leave such compelling statements out of the PR. "Hundreds" certainly speaks from a position of strength, assuming it's true.


Share
New Message
Please login to post a reply